Tag: infectious disease diagnostics testing market trends

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Infectious Disease Diagnostics Testing Market Forecast: Value Set To Climb From $46.48 Billion To $65.49 Billion

The infectious disease diagnostics testing market size has experienced substantial expansion in recent years. It is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth has been driven by factors such as the increasing occurrence of infectious diseases, a surge in respiratory infection cases, the development of diagnostic laboratory facilities, heightened understanding of the importance of early disease detection, and increased governmental attention on managing diseases.

The infectious disease diagnostics testing market is expected to undergo significant expansion in the coming years. It is anticipated to grow to $65.49 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.0%. The projected growth during this period stems from factors such as the escalating risk of global pandemics, an increasing demand for rapid diagnostic solutions, growing investments in healthcare diagnostics, the expansion of disease surveillance programs, and a rising burden of tropical and viral diseases. Noteworthy trends during the forecast period encompass a surging demand for swift and early detection of infectious diseases, increasing adoption of point-of-care infectious disease tests, greater use of molecular diagnostics for pathogen identification, the broadening scope of diagnostic testing for both emerging and re-emerging infections, and an enhanced focus on large-scale disease screening and surveillance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=34311314&type=smp&name=Infectious%20Disease%20Diagnostics%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infectious Disease Diagnostics Testing Market Growth Factors: What’s Supporting Expansion?

The increasing incidence of respiratory infections is projected to fuel the expansion of the infectious disease diagnostic testing market in the future. These infections target the respiratory system, encompassing the nose, throat, airways, and lungs. The growing number of respiratory infections stems from viral and bacterial spread via close contact with affected people, inadequate hygiene, congested living environments, and seasonal climatic shifts. Crucially, infectious disease diagnostic testing plays a vital role in diagnosing and managing respiratory infections by accurately pinpointing pathogens like bacteria and viruses within patient specimens. For example, data from February 2024 released by the Canadian Institute for Health Information, a Canada-based non-profit body, showed a 32% rise in hospitalizations for acute upper respiratory infections, climbing from 2,114 cases in 2022 to 2,797 cases in 2023. Consequently, the escalating occurrence of respiratory infections is a key driver for the infectious disease diagnostic testing market.

Infectious Disease Diagnostics Testing Market Segment Outlook: Which Categories Are Growing Fastest?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Infectious Disease Diagnostics Testing Market Industry Trends: What’s Reshaping Demand?

Leading companies in the infectious disease diagnostic testing market are advancing innovative technologies designed for the swift and reliable detection of critical infections. Infectious disease diagnostics focuses on identifying pathogens, such as bacteria, viruses, or parasites, to inform diagnosis and guide appropriate treatment. For instance, in January 2025, QIAGEN, a Germany-based biotechnology company, launched new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel. These were introduced alongside the previously authorized Respiratory SARS-CoV-2 Panel, all having secured approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system employs multiplex real-time PCR with single-use cartridges to simultaneously detect multiple pathogens, delivering results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels enhance diagnostic speed and accuracy compared to traditional methods, thereby enabling timely treatment, improving patient outcomes, and easing burdens on healthcare systems. The system additionally offers configurable setups and cloud connectivity for remote monitoring and efficient data management.

Infectious Disease Diagnostics Testing Market Industry Leaders And Competitive Landscape

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

View The Full Infectious Disease Diagnostics Testing Market Report:

https://thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infectious Disease Diagnostics Testing Market Regional Analysis And Leading Geography

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Infectious Disease Diagnostics Testing Market During The 2026–2030 Period?

The infectious disease diagnostics testing market size has experienced swift expansion in recent years. It is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. This historical expansion is attributable to several factors, including the escalating prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, increasing awareness of early disease diagnosis, and a heightened government focus on disease control.

The infectious disease diagnostics testing market size is projected to undergo significant expansion in the coming years. By 2030, its value is expected to reach $65.49 billion, expanding at a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is primarily driven by the increasing threat of global pandemics, a heightened need for rapid diagnostic solutions, rising investments within healthcare diagnostics, the expansion of disease surveillance programs, and the increasing burden of tropical and viral diseases. Furthermore, prominent trends anticipated for this period include a surging demand for swift and early detection of infectious diseases, the broader adoption of point-of-care infectious disease tests, a growing reliance on molecular diagnostics for pathogen identification, an expansion of diagnostic testing for emerging and re-emerging infections, and an intensified focus on extensive disease screening and surveillance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

What Core Drivers Are Transforming The Infectious Disease Diagnostics Testing Market?

The expected growth of the infectious disease diagnostic testing market is significantly influenced by a rise in respiratory infections, which impact parts of the respiratory system such as the nose, throat, airways, and lungs. These increasing infections are attributable to viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal weather changes. Infectious disease diagnostic testing plays a vital role in the diagnosis and treatment of these infections by accurately identifying pathogens like bacteria and viruses in patient samples. For example, in February 2024, the Canadian Institute for Health Information, a Canada-based non-profit organization, reported a 32% increase in hospitalizations for acute upper respiratory infections, climbing from 2,114 in 2022 to 2,797 cases in 2023. This upward trend in respiratory infections is thus propelling the infectious disease diagnostic testing market.

What Are The Core Segment Classifications In The Infectious Disease Diagnostics Testing Market?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Which Trends Are Expected To Shape The Infectious Disease Diagnostics Testing Market?

Leading companies in the infectious disease diagnostic testing market are advancing sophisticated technologies for the rapid and reliable identification of critical infections. Infectious disease diagnostics involves pinpointing pathogens, such as bacteria, viruses, or parasites, to guide diagnosis and subsequent treatment. For example, in January 2025, QIAGEN, a biotechnology company based in Germany, launched new QIAstat-Dx syndromic testing panels in India. These include the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, introduced alongside the previously authorized Respiratory SARS-CoV-2 Panel, all of which received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system utilizes multiplex real-time PCR with single-use cartridges to detect multiple pathogens concurrently, providing results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels enhance the speed and accuracy of diagnosis compared to traditional methods, facilitating timely treatment, improving patient outcomes, and reducing the burden on healthcare systems. Additionally, the system offers configurable setups and cloud connectivity for remote monitoring and efficient data management.

Which Organizations Are Operating Within The Infectious Disease Diagnostics Testing Market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

Access The Complete Infectious Disease Diagnostics Testing Market Report:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

What Is The Largest Regional Market In The Infectious Disease Diagnostics Testing Market?

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Infectious Disease Diagnostics Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company

Disposable Incontinence Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-incontinence-products-global-market-report

Urinary Incontinence Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-and-pelvic-organ-prolapse-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Infectious Disease Diagnostics Testing Market During 2026–2030?

The infectious disease diagnostics testing market has experienced rapid expansion recently. Projections indicate a rise from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth stemmed from factors such as the increasing prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, greater awareness of early disease diagnosis, and enhanced government focus on disease control.

The infectious disease diagnostics testing market is set to experience significant expansion over the next few years. It is forecast to reach $65.49 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This projected growth can be ascribed to several factors, including the increasing threat of global pandemics, a heightened need for rapid diagnostic solutions, rising investments in healthcare diagnostics, the expansion of disease surveillance programs, and the increasing burden of tropical and viral diseases. Prominent trends throughout this forecast period encompass an escalating demand for prompt and early infectious disease detection, the growing adoption of point-of-care infectious disease tests, an increased reliance on molecular diagnostics for pathogen identification, the broadening scope of diagnostic testing for emerging and re-emerging infections, and an intensified focus on large-scale disease screening and surveillance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

What Primary Drivers Are Shaping The Infectious Disease Diagnostics Testing Market?

The future expansion of the infectious disease diagnostic testing market is anticipated to be driven by an increase in respiratory infections. These infections affect the respiratory system, encompassing the nose, throat, airways, and lungs. The growing number of respiratory infections is attributed to viral and bacterial transmission through close contact with infected individuals, suboptimal hygiene, crowded living conditions, and fluctuating seasonal weather patterns. Infectious disease diagnostic testing is crucial for diagnosing and treating respiratory infections because it can precisely identify pathogens such as bacteria and viruses in patient samples. For instance, in February 2024, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, hospitalizations for acute upper respiratory infections increased by 32% from 2,114 in 2022 to 2,797 cases in 2023. Consequently, the rise in respiratory infections is stimulating the infectious disease diagnostic testing market.

How Is The Infectious Disease Diagnostics Testing Market Broken Down By Segment Categories?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

What Trends Are Affecting The Growth Of The Infectious Disease Diagnostics Testing Market?

Leading companies in the infectious disease diagnostic testing market are advancing innovative technologies for the rapid and reliable identification of critical infections. Infectious disease diagnostics focuses on pinpointing pathogens, such as bacteria, viruses, or parasites, which is essential for guiding diagnosis and treatment. For instance, in January 2025, QIAGEN, a Germany-based biotechnology company, introduced new QIAstat-Dx syndromic testing panels in India, specifically the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, which were launched alongside the previously authorized Respiratory SARS-CoV-2 Panel, all approved by India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system employs multiplex real-time PCR with single-use cartridges to detect multiple pathogens concurrently, providing results in approximately an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy when compared to traditional methods, thereby enabling timely treatment, enhancing patient outcomes, and alleviating burdens on healthcare systems. The system also features configurable setups and cloud connectivity, facilitating remote monitoring and efficient data management.

Which Players Are Present In The Infectious Disease Diagnostics Testing Market Space?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

Get The Full Infectious Disease Diagnostics Testing Market Report:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Region Has The Greatest Market Share In The Infectious Disease Diagnostics Testing Market?

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Infectious Disease Diagnostics Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company

Disposable Incontinence Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-incontinence-products-global-market-report

Urinary Incontinence Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-and-pelvic-organ-prolapse-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Infectious Disease Diagnostics Testing Market Between 2026 And 2030?

The infectious disease diagnostics testing market size has experienced significant expansion recently. This market is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth has been driven by factors such as the increasing prevalence of infectious diseases, a rise in respiratory infection cases, the expanding infrastructure of diagnostic laboratories, heightened awareness regarding early disease diagnosis, and a greater government emphasis on disease control.

The market for infectious disease diagnostics testing is projected to experience robust expansion over the coming years. It is anticipated to reach a valuation of $65.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is attributable to several factors, including the escalating risk of global pandemics, the increasing need for prompt diagnostic solutions, greater investments in healthcare diagnostics, the expansion of disease surveillance initiatives, and the increasing prevalence of tropical and viral diseases. Key trends shaping the forecast period encompass a growing requirement for swift and early detection of infectious diseases, the increasing uptake of point-of-care infectious disease tests, a rise in the application of molecular diagnostics for identifying pathogens, the broadening of diagnostic testing for both emerging and re-emerging infections, and an intensified emphasis on large-scale disease screening and surveillance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

What Major Drivers Are Influencing Demand In The Infectious Disease Diagnostics Testing Market?

An expected increase in respiratory infections is poised to drive the growth of the infectious disease diagnostic testing market in the future. These infections impact the respiratory system, including the nose, throat, airways, and lungs. The escalating respiratory infections are a result of viral and bacterial transmission through close contact with infected individuals, insufficient hygiene practices, densely populated living spaces, and seasonal changes in weather patterns. Infectious disease diagnostic testing is crucial for both diagnosing and treating respiratory infections, as it allows for the precise identification of pathogens such as bacteria and viruses in patient samples. For instance, in February 2024, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, hospitalizations for acute upper respiratory infections saw an increase of 32% from 2,114 cases in 2022 to 2,797 cases in 2023. Therefore, the rise in respiratory infections is a key driver for the infectious disease diagnostic testing market.

Which Market Segments Are Examined In The Infectious Disease Diagnostics Testing Market Study?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Which Trends Are Influencing The Infectious Disease Diagnostics Testing Market?

Leading companies in the infectious disease diagnostic testing market are developing innovative technologies to quickly and reliably identify critical infections. Infectious disease diagnostics involves pinpointing pathogens, such as bacteria, viruses, or parasites, to inform diagnosis and treatment strategies. For instance, in January 2025, QIAGEN, a Germany-based biotechnology firm, introduced new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel. These were launched alongside the previously authorized Respiratory SARS-CoV-2 Panel, all having received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system utilizes multiplex real-time PCR with single-use cartridges to detect multiple pathogens simultaneously, providing results in approximately an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy when compared to traditional methods, thus enabling timely treatment, enhancing patient outcomes, and reducing the workload on healthcare systems. The system additionally offers configurable setups and cloud connectivity for remote monitoring and streamlined data management.

Who Are The Primary Competitors In The Infectious Disease Diagnostics Testing Market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

Read the full infectious disease diagnostics testing market report here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Infectious Disease Diagnostics Testing Market?

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infectious Disease Diagnostics Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company

Disposable Incontinence Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-incontinence-products-global-market-report

Urinary Incontinence Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-and-pelvic-organ-prolapse-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Infectious Disease Diagnostics Testing Market in 2030?

The infectious disease diagnostics testing market size has undergone rapid expansion in recent years. Projections indicate it will grow from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. The growth observed in the past period is attributable to the increasing prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, growing awareness about early disease diagnosis, and an increased governmental focus on disease control.

The infectious disease diagnostics testing market is anticipated to experience substantial growth over the coming years. It is projected to reach $65.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is primarily driven by factors such as the increasing global pandemic risk, a heightened need for swift diagnostic solutions, greater financial commitments in healthcare diagnostics, the broadening scope of disease surveillance initiatives, and the escalating prevalence of tropical and viral diseases. Key developments expected within this period include a surging demand for prompt and early detection of infectious diseases, the increasing uptake of point-of-care tests for infectious conditions, a greater reliance on molecular diagnostics for identifying pathogens, the broadening of diagnostic testing efforts for both emerging and re-emerging infections, and an enhanced focus on extensive disease screening and surveillance activities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

What Drivers Are Influencing Production Trends In The Infectious Disease Diagnostics Testing Market?

The anticipated increase in respiratory infections is projected to fuel the expansion of the infectious disease diagnostic testing market moving forward. These infections target the respiratory system, encompassing the nose, throat, airways, and lungs. The surge in respiratory infections stems from viral and bacterial spread via close interaction with infected persons, inadequate hygiene, cramped living environments, and cyclical weather changes. Accurate identification of pathogens like bacteria and viruses in patient specimens makes infectious disease diagnostic testing crucial for the diagnosis and management of respiratory infections. As an illustration, figures from February 2024, released by the Canadian Institute for Health Information, a Canada-based non-profit organization, revealed a 32% rise in hospital admissions for acute upper respiratory infections, climbing from 2,114 in 2022 to 2,797 cases in 2023. Consequently, the uptick in respiratory infections is stimulating the infectious disease diagnostic testing market.

Which Segments Are Gaining Traction In The Infectious Disease Diagnostics Testing Market?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Which Competitive Trends Are Impacting The Structure Of The Infectious Disease Diagnostics Testing Market?

Leading companies in the infectious disease diagnostic testing market are developing advanced technologies for the swift and reliable identification of critical infections. Infectious disease diagnostics involves the detection of pathogens, such as bacteria, viruses, or parasites, to guide both diagnosis and subsequent treatment. For example, in January 2025, QIAGEN, a German biotechnology company, introduced new QIAstat-Dx syndromic testing panels in India. These included the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, offered alongside the previously authorized Respiratory SARS-CoV-2 Panel, all of which received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system leverages multiplex real-time PCR with single-use cartridges to simultaneously detect multiple pathogens, yielding results in approximately one hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels significantly improve diagnostic speed and accuracy compared to conventional methods, thereby enabling timely treatment, enhancing patient outcomes, and reducing the strain on healthcare systems. The system additionally features configurable setups and cloud connectivity, facilitating remote monitoring and efficient data management.

Who Are The Primary Competitors In The Global Infectious Disease Diagnostics Testing Market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Regions Are Projected To Dominate The Infectious Disease Diagnostics Testing Market In The Coming Years?

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Infectious Disease Diagnostics Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company

Disposable Incontinence Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-incontinence-products-global-market-report

Urinary Incontinence Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-and-pelvic-organ-prolapse-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the infectious disease diagnostics testing market from 2025–2034 with trusted insights from The Business Research Company

How Is The Infectious Disease Diagnostics Testing Market Size Expected To Expand Over 2029-2034?

The infectious disease diagnostics testing market size has experienced robust expansion over the past few years. It is projected to expand from $38.52 billion in 2024 to $42.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. This historical expansion can be linked to factors such as an increase in disease outbreaks like SARS, Ebola, and Zika; heightened awareness among medical professionals and the general populace regarding the significance of prompt detection and avoidance of infectious ailments; an uptick in government-sponsored initiatives for monitoring, managing, and preventing diseases; the greater ease with which infectious diseases spread due to increased global travel and commerce; and enhanced expenditure on healthcare, especially in developing economies.

The infectious disease diagnostics testing market size is anticipated to experience robust growth in the coming years. It is projected to expand to $60.71 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.5%. This projected growth is driven by the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the increasing focus on personalized medicine and targeted therapies, a rising demand for rapid and on-site testing solutions, a greater emphasis on epidemiological surveillance and early detection systems, and heightened research and development activities aimed at creating novel diagnostic technologies and biomarkers. Significant trends during this forecast period involve the miniaturization and portability of diagnostic devices, the adoption of multiplex assays capable of simultaneously detecting multiple pathogens, the integration of digital health solutions like mobile apps and telemedicine platforms, the utilization of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for quick and sensitive identification of infectious agents, and the incorporation of AI and machine learning algorithms into diagnostic platforms.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which Market Factors Are Fueling The Infectious Disease Diagnostics Testing Industry Growth?

The infectious disease diagnostic testing market is projected to grow due to an anticipated increase in respiratory infections. These infections impact the respiratory system, including the nose, throat, airways, and lungs. The rising incidence of respiratory infections is attributed to viral and bacterial transmission through close contact with infected individuals, insufficient hygiene practices, crowded living conditions, and seasonal shifts in weather patterns. Infectious disease diagnostic testing is vital for diagnosing and managing respiratory infections because it can precisely identify pathogens such as bacteria and viruses in patient samples. For example, the Canadian Institute for Health Information, a Canada-based non-profit organization, stated in February 2024 that hospitalizations for acute upper respiratory infections rose by 32% from 2,114 in 2022 to 2,797 cases in 2023. Therefore, the increase in respiratory infections is a key factor driving the infectious disease diagnostic testing market.

Which Categories Are Covered In The Infectious Disease Diagnostics Testing Market Segmentation Analysis?

The infectious disease diagnostics testingmarket covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Which Market Trends Are Expected To Define The Future Of The Infectious Disease Diagnostics Testing Market?

Leading companies within the infectious disease diagnostic testing market are concentrating on developing innovative technologies, such as molecular diagnostics platforms, to maintain their market presence. Molecular diagnostics platforms are sophisticated systems designed for detecting and analyzing nucleic acids (DNA or RNA) from biological samples for diagnostic purposes. As an illustration, in May 2022, Becton Dickinson, and Company, a US-based medical technology enterprise, unveiled the BD COR System, a fully automated, high-throughput molecular diagnostics platform for infectious diseases. This platform integrates and automates the entire molecular laboratory workflow, from sample processing to diagnostic results, thereby removing the necessity for manual specimen sorting and enabling lab technicians to focus on higher-value activities. The system has the capacity to process up to 1,700 specimens and deliver results within 24 hours, providing high-throughput functionalities and advanced genotyping for conditions like HPV and STIs.

Which Organizations Are At The Forefront Of The Infectious Disease Diagnostics Testing Market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Infectious Disease Diagnostics Testing Market?

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2025, By The Business Research Company

Non Animal Alternatives Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Pharmaceutical Sterility Testings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Pcr And Realtime Pcr Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Infectious Disease Diagnostics Testing Market Size Likely To Evolve From 2025 Through 2034?

The market for diagnostics testing in the field of infectious diseases has seen considerable expansion during recent times, projected to increase from $38.52 billion in 2024 to reach $42.24 billion by 2025, reflecting a compound annual growth rate of 9.7%. This upward trajectory in the past era stems from several factors, including the emergence of significant disease episodes like SARS, Ebola, and Zika, heightened consciousness among both medical personnel and the public regarding the critical nature of swift identification and prophylaxis of contagious illnesses, an uptick in state-sponsored initiatives focusing on tracking, managing, and stopping disease spread, the acceleration of global movement and commerce which aids in transmitting infections, and escalating expenditures on healthcare, especially within developing nations.

Anticipating robust expansion, the market for infectious disease diagnostics testing is projected to reach a valuation of $60.71 billion by 2029, demonstrating a consistent compound annual growth rate (CAGR) of 9.5%; this upward trajectory is fueled by several key factors, including the persistent appearance of previously unseen disease agents like evolving influenza variants or novel coronaviruses, a broader movement towards tailored medical treatments and specific therapeutic approaches, an escalating need for diagnostic tools that provide results quickly and can be utilized immediately at the point of care, heightened concentration on systematic tracking of disease spread alongside systems designed for prompt identification, and greater investment in R&D efforts aimed at creating innovative diagnostic methods and biological markers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which Drivers Are Shaping The Infectious Disease Diagnostics Testing Industry’s Market Share?

Anticipation is high for the infectious disease diagnostic testing market’s expansion, fueled primarily by an expected surge in respiratory infection occurrences. These infections impact the structures involved in breathing, spanning from the nasal passages and throat down to the airways and lungs. The heightened prevalence of these infections stems from several factors, including pathogen spread (both viral and bacterial) facilitated by proximity to affected persons, inadequate sanitation habits, densely populated environments, and shifts in climate across seasons. Accurately pinpointing bacteria and viruses within patient specimens makes infectious disease diagnostic testing a critical tool for managing and treating respiratory illnesses. To illustrate this impact, data from the Canadian Institute for Health Information, a Canadian nonprofit, showed a significant uptick in hospital admissions for acute upper respiratory infections, climbing 32 percent from 2,114 instances in 2022 to 2,797 in 2023 by February 2024; consequently, this increase in respiratory ailments serves as a major impetus for the growth trajectory of the infectious disease diagnostic testing sector.

What Are The Primary Types Of Segments Analyzed In The Infectious Disease Diagnostics Testing Market?

The infectious disease diagnostics testingmarket covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Which Ongoing Trends Are Expected To Shape The Infectious Disease Diagnostics Testing Market Outlook?

To maintain their standing within the market landscape, leading firms engaged in the infectious disease diagnostic testing sector are concentrating efforts on creating cutting-edge solutions, exemplified by molecular diagnostics systems. These sophisticated platforms are engineered for the identification and analysis of genetic material, specifically DNA or RNA, sourced from biological specimens for diagnostic determination. As an illustration, in May of 2022, the American medical device corporation, Becton Dickinson and Company, introduced the BD COR System, which represents a completely automated, high-capacity molecular diagnostics platform for infectious diseases. This system streamlines and automates the entire molecular laboratory process, stretching from initial sample handling right through to the final diagnostic readouts, thereby removing the requirement for manual specimen arrangement and allowing laboratory personnel to dedicate their time to more critical responsibilities. Capable of analyzing as many as 1,700 samples and outputting findings inside a day, this apparatus provides both substantial processing volume and sophisticated genotyping capabilities for conditions including Human Papillomavirus and sexually transmitted infections.

Who Are The Core Companies Influencing The Infectious Disease Diagnostics Testing Market Landscape?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Region Is Projected To Lead The Infectious Disease Diagnostics Testing Market During The Forecast Period?

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Infectious Disease Diagnostics Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2025, By The Business Research Company

Non Animal Alternatives Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Pharmaceutical Sterility Testings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Pcr And Realtime Pcr Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Infectious Disease Diagnostics Testing Market Size From 2025 to 2034?

There has been a significant expansion in the market size of infectious disease diagnostics testing in the most recent years. The market, which was valued at $38.52 billion in 2024, is projected to increase to $42.24 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. This historical growth can be largely attributed to the surge in disease outbreaks such as SARS, Ebola, and Zika, an enhanced awareness among medical professionals and the broader public about the critical need for early diagnosis and prevention of infectious diseases, a rise in disease control, surveillance, and prevention programs funded by governments, a spike in global trade and travel that has accelerated the transmission of infectious diseases and elevated healthcare expenditure, particularly in developing economies.

Expectations are high for substantial growth in the market size for infectious disease diagnostics testing in the approaching years. It’s projected to escalate to $60.71 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. The predicted growth in this period can be linked to several factors. These include the ongoing discovery of new pathogens, including new variants of influenza or COVID-19, the transition towards personalized medicine and targeted treatments, increased need for swift and local testing solutions, an intensified focus on epidemiological surveillance and early detection systems, and a rise in research and development endeavors aiming at creating new diagnostic techniques and biomarkers. Key trends for the forecast period encompass the miniaturization and mobility of diagnostic gadgets, the implementation of multiplex assays that can identify various pathogens at once, inclusion of digital health solutions like mobile applications and telemedicine platforms, the utilization of next-generation sequencing (NGS) technologies in infectious disease diagnostics, progress in biosensor technologies facilitating quick and sensitive identification of infectious diseases, and the incorporation of AI and machine learning algorithms into diagnostic systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which Primay Drivers Are Accelerating Growth in the Infectious Disease Diagnostics Testing Market?

The upward trend in respiratory infections is projected to drive the infectious disease diagnostic testing market’s expansion. These infections, which affect the respiratory system including the nose, throat, airways, and lungs, are on the rise due to viral and bacterial transmission via close contact with infected people, poor sanitary practices, overcrowded living situations, and seasonal weather fluctuations. The crucial role of infectious disease diagnostic testing in pinpointing pathogens such as viruses and bacteria in patient samples makes it indispensable for diagnosing and treating respiratory infections. To illustrate, in February 2024, the Canadian Institute for Health Information, a non-profit based in Canada, reported a 32% increase in hospitalizations for acute upper respiratory infections, going from 2,114 cases in 2022 up to 2,797 in 2023. As a result, the infectious disease diagnostic testing market is being propelled by the surge in respiratory infections.

Which Primary Segments of the Infectious Disease Diagnostics Testing Market Are Driving Growth and Industry Transformations?

The infectious disease diagnostics testingmarket covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Infectious Disease Diagnostics Testing Market?# Market?

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Infectious Disease Diagnostics Testing Industry Dynamics?

Leading enterprises in the infectious disease diagnostic testing market are prioritizing the advancement of novel technologies, such as molecular diagnostics platforms, to maintain their competitive standing. These platforms are intricate systems engineered to detect and examine nucleic acids (DNA or RNA) from biological specimens for diagnostic objectives. For example, in May 2022, Becton Dickinson, a US-based medical technology firm and Company, introduced the BD COR System. This is a fully integrated, high-capacity infectious disease molecular diagnostics platform that automates the entire molecular lab workflow from sample management to obtaining diagnostic results, thereby eliminating manual specimen sorting and allowing lab technicians to focus on more specialized tasks. The platform is capable of processing up to 1,700 specimens and providing results within 24 hours, demonstrating its high-capacity processing capabilities and sophisticated genotyping for diseases, including HPV and STIs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

What Parameters Are Used to Define the Infectious Disease Diagnostics Testing Market?

Infectious disease diagnostics testing refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient’s body. These tests are crucial for diagnosing infectious diseases and guiding appropriate treatment decisions. Infectious disease diagnostics testing plays a vital role in controlling the spread of infectious diseases, guiding treatment decisions, and monitoring outbreaks.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Infectious Disease Diagnostics Testing Market Size Shifted, And What Is the Outlook Through 2034?

The market size for diagnostics testing of infectious diseases has seen rapid expansion recently. It is projected to rise from $38.52 billion in 2024 to $42.56 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historic period include escalating outbreaks of diseases such as SARS, Ebola, and Zika, heightened awareness about the significance of early detection and prevention of infectious diseases among both healthcare professionals and the public, increased government funding for disease surveillance, control, and prevention initiatives, a surge in global travel and trade enabling disease spread, and elevated healthcare expenditure, especially in developing economies.

How Much Will the Infectious Disease Diagnostics Testing Market Be Worth in 2029?

Expectations are high for the infectious disease diagnostics testing market, with forecasts predicting massive expansion over the coming years. It is anticipated to reach a valuation of $62.58 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.1%. This growth throughout the forecast period is largely due to the constant appearance of new pathogens like advanced strains of influenza or COVID-19, the push towards personalized medicine and targeted treatments, an increased demand for quick, point-of-care testing solutions, a growing focus on epidemiological surveillance and early detection systems, as well as intensified research and development efforts to create innovative diagnostic technologies and biomarkers. Key trends that are expected to shape the market during this forecast period include the downsizing and making diagnostic devices portable, the use of multiplex assays capable of identifying several pathogens at once, the incorporation of digital health solutions such as mobile applications and telemedicine platforms, the application of next-generation sequencing (NGS) technologies in infectious disease diagnostics, the progression of biosensor technologies for swift and sensitive detection of infectious agents, and the incorporation of AI and machine learning algorithms into diagnostic platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which is the Largest Company in the Infectious Disease Diagnostics Testing Market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

What Are the Main Market Drivers in the Infectious Disease Diagnostics Testing Industry?

The anticipated surge in respiratory infections is predicted to drive the growth of the infectious disease diagnostic testing market. Respiratory infections, which impact the respiratory system including the nose, throat, airways, and lungs, are on the rise due to viral and bacterial spread. Causes include close interaction with infected people, inadequate hygiene habits, congested living environments, and seasonal weather changes. Diagnosing and treating these infections crucially rely on infectious disease diagnostic testing as it accurately detects pathogens such as bacteria and viruses in patient samples. For example, the Canadian Institute for Health Information, a non-profit organization in Canada, reported in February 2024 that hospitalizations due to acute upper respiratory infections saw a 32% rise, increasing from 2,114 cases in 2022 to 2,797 cases in 2023. Consequently, this surge in respiratory infections is fueling the expansion of the infectious disease diagnostic testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

How Is the Infectious Disease Diagnostics Testing Market Segments Structured?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

What Strategic Trends Are Transforming the Infectious Disease Diagnostics Testing Market?

Leading firms in the infectious disease diagnostic testing market are placing emphasis on the creation of groundbreaking technologies, like molecular diagnostics platforms, in order to maintain their market presence. Molecular diagnostics platforms are complex mechanisms designed for the detection and analysis of nucleic acids (DNA or RNA) from organic samples for diagnostic applications. A good example of this is when Becton Dickinson and Company, a medical technology firm based in the US, introduced the BD COR System in May 2022. This system, a fully automated, high-throughput infectious disease molecular diagnostics platform, integrates and automates the entire molecular laboratory procedure from sample examination to diagnostic outcomes, eliminating the requirement for manual sample classification and allowing lab professionals to focus on higher-level tasks. The system is capable of processing up to 1,700 specimens and producing results in 24 hours, providing high-throughput functionalities and superior genotyping for diseases like HPV and STIs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Global Regions Offer the Highest Growth in the Infectious Disease Diagnostics Testing Market?

North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831

This Report Delivers Insight On:

1. How big is the infectious disease diagnostics testing market, and how is it changing globally?

2. Who are the major companies in the infectious disease diagnostics testing market, and how are they performing?

3. What are the key opportunities and risks in the infectious disease diagnostics testing market right now?

4. Which products or customer segments are growing the most in the infectious disease diagnostics testing market?

5. What factors are helping or slowing down the growth of the infectious disease diagnostics testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model